Answers are grounded in this paper and cite their sources.
Luteinising hormone-releasing hormone (LHRH) analogue administration can reduce the size of uterine leiomyomata and its pre-operative use prior to myomectomy or hysterectomy is discussed. It is concluded that pre-operative use of LHRH analogues does have a role in gynaecological surgery.
No takes yet. Share an insight, caveat, or question.
Thomas G. Stovall (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: